Emergency hospitalizations for adverse drug events in older Americans

New England Journal of Medicine

Volumn 365, Issue 21, 2011, Pages 2002-2012

  Budnitz, Daniel S ^a   Lovegrove, Maribeth C ^a   Shehab, Nadine ^a   Richards, Chesley L ^b,c  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; HEMATOLOGIC AGENT; HORMONE; INSULIN; ORAL ANTIDIABETIC AGENT; WARFARIN;

ADVERSE DRUG REACTION; AGED; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIZZINESS; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SAFETY; DYSPNEA; ELECTROLYTE DISTURBANCE; EMERGENCY WARD; EPISTAXIS; FALLING; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GENITAL BLEEDING; GERIATRICS; HEALTH CARE MANAGEMENT; HEALTH SURVEY; HEART ARRHYTHMIA; HEART RATE; HEMOPTYSIS; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; LETHARGY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NATIONAL ELECTRONIC INURY SURVEILLANCE SYSTEM COOPERATIVE ADVERSE DRUG EVENT SURVEILLANCE REPORT; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; SKIN BLEEDING; SYNCOPE; UNCONSCIOUSNESS; UNITED STATES; WEAKNESS; WOUND HEMORRHAGE;

EID: 81855169543     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1103053     Document Type: Article

References (40)

1. Kocher R, Emanuel EJ, DeParle NA. The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med 2010;153:536-9.
2. HealthCare.gov. Partnership for patients: better care, lower costs. Washington, DC: Department of Health and Human Services (http://www.healthcare. gov/center/ programs/partnership/index.html).
3. Patterns of medication use in the United States, 2006: a report from the Slone Survey. Boston: Slone Epidemiology Center at Boston University (http://www.bu .edu/slone/SloneSurvey/AnnualRpt/ SloneSurveyWebReport2006.pdf).
4. ElDesoky ES. Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007;14:488-98.
5. McLean AJ, Le Couteur DG. Aging, biology, and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-84. (Pubitemid 38720828)
6. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.
7. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755-65.
8. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. (Pubitemid 46072098)
9. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6.
10. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (NEISS-CADES). Med Care 2007;45:Suppl 2:S96-S102.
11. Ambulatory health care data. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/nchs/ahcd.htm).
12. Healthcare Effectiveness Data and Information Set (HEDIS). 2011 Final NDC lists: use of high-risk medications in the elderly (DAE). Washington, DC: National Committee on Quality Assurance (http:// www.ncqa.org/tabid/1274/ Default.aspx).
13. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24. [Erratum, Arch Intern Med 2004;164:298.] (Pubitemid 37517412)
14. National Electronic Injury Surveillance System All Injury Program: sample design and implementation. Washington, DC: Consumer Product Safety Commission, 2002.
15. Kish L. Survey sampling. New York: Wiley Interscience, 1995.
16. Bridged-race population estimates, United States: July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin, compiled from 1990-1999 bridged-race intercensal population estimates and 2000-2009 (Vintage 2009) bridged-race postcensal population estimates, on CDC WONDER on-line database. Atlanta: Centers for Disease Control and Prevention (http://wonder.cdc.gov/ bridged-race-v2009.html).
17. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002;50:1962-8. (Pubitemid 35462441)
18. Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10:113-9. (Pubitemid 32590942)
19. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-6. (Pubitemid 34925265)
20. Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm 2003;60:253-9. (Pubitemid 36749049)
21. Buie VC, Owings MF, DeFrances CJ, Golosinskiy A. National Hospital Discharge Survey: 2006 summary. Vital Health Stat 2010;13:168.
22. HCUPnet: Healthcare Cost and Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality (http:// hcupnet.ahrq.gov).
23. Wachter RM. Patient safety at ten: unmistakable progress, troubling gaps. Health Aff (Millwood) 2010;29:165-73.
24. Kim MM, Metlay J, Cohen A, et al. Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults. Pharmacoepidemiol Drug Saf 2010;19:731-6.
25. Zhang Y, Baicker K, Newhouse JP. Geographic variation in the quality of prescribing. N Engl J Med 2010;363:1985-8.
26. Curtiss FR, Fairman KA. Protecting patients from adverse drug events: propoxyphene, PIMs, and drugs to avoid in older adults. J Manag Care Pharm 2011; 17:60-9.
27. Page RL II, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006;4:297-305.
28. Gage BF. Can we rely on RE-LY? N Engl J Med 2009;361:1200-2.
29. Streiff MB, Kraus PS, Pronovost P. Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement. Ann Pharmacother 2010;44:733-6.
30. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists. Chest 2008;133:Suppl:160S-198S.
31. Spinler SA. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease. Pharmacotherapy 2009;29:812-21.
32. Shehab N, Sperling LS, Kegler SR, Budnitz DS. National estimates of emergency department visits for hemorrhagerelated adverse events from clopidogrel plus aspirin and from warfarin. Arch Intern Med 2010;170:1926-33.
33. Pogach L, Aron D. Balancing hypoglycemia and glycemic control: a public health approach for insulin safety. JAMA 2010;303:2076-7.
34. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84. (Pubitemid 47049724)
35. Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011;59:1513-20.
36. NQF-endorsed standards. Washington, DC: National Quality Forum (http://www .qualityforum.org/Measures-List.aspx).
37. Wears RL, Nelson LS. Believing is seeing. Ann Emerg Med 2010;55:511-2.
38. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009;302:758-66.
39. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004;164:305-12. (Pubitemid 38176470)
40. Burt CW. National trends in use of medications in office-based practice, 1985-1999. Health Aff (Millwood) 2002;21:206-14.